154 related articles for article (PubMed ID: 8252482)
101. Prognostic factors in well-differentiated early-stage epithelial ovarian cancer.
Schueler JA; Cornelisse CJ; Hermans J; Trimbos JB; van der Burg ME; Fleuren GJ
Cancer; 1993 Feb; 71(3):787-95. PubMed ID: 8431861
[TBL] [Abstract][Full Text] [Related]
102. Tumor progression, histologic grading and DNA-ploidy as predictive factors of lymphogenous metastasis in primary carcinoma of the Fallopian tube.
Klein M; Graf AH; Rosen A; Lahousen M; Hacker GW
Cancer Lett; 2002 Mar; 177(2):209-14. PubMed ID: 11825669
[TBL] [Abstract][Full Text] [Related]
103. DNA ploidy and cell-cycle analysis in pancreatic and ampullary carcinoma: flow cytometric study of formalin-fixed paraffin-embedded tissue.
Baisch H; Klöppel G; Reinke B
Virchows Arch A Pathol Anat Histopathol; 1990; 417(2):145-50. PubMed ID: 2114693
[TBL] [Abstract][Full Text] [Related]
104. Pathology and ploidy in the prognosis of gastric cancer with no extranodal metastasis.
Rugge M; Sonego F; Panozzo M; Baffa R; Rubio J; Farinati F; Nitti D; Ninfo V; Ming SC
Cancer; 1994 Feb; 73(4):1127-33. PubMed ID: 8313314
[TBL] [Abstract][Full Text] [Related]
105. The relative prognostic value of flow cytometric DNA analysis and conventional clinicopathologic criteria in patients with operable rectal carcinoma.
Scott NA; Rainwater LM; Wieand HS; Weiland LH; Pemberton JH; Beart RW; Lieber MM
Dis Colon Rectum; 1987 Jul; 30(7):513-20. PubMed ID: 3595373
[TBL] [Abstract][Full Text] [Related]
106. Cervical carcinoma DNA content, S-fraction, and malignancy grading. I. Interrelationships.
Johnson TS; Adelson MD; Sneige N; Williamson KD; Lee AM; Katz R
Gynecol Oncol; 1987 Jan; 26(1):41-56. PubMed ID: 3792935
[TBL] [Abstract][Full Text] [Related]
107. DNA cell-cycle analysis of cervical cancer by flow cytometry using simultaneous cytokeratin labelling for identification of tumour cells.
Kimmig R; Kapsner T; Spelsberg H; Untch M; Hepp H
J Cancer Res Clin Oncol; 1995; 121(2):107-14. PubMed ID: 7533765
[TBL] [Abstract][Full Text] [Related]
108. Is radical hysterectomy always necessary in early cervical cancer?
Jakobsen A; Bichel P; Ahrons S; Nyland M; Knudsen J
Gynecol Oncol; 1990 Oct; 39(1):80-1. PubMed ID: 2227577
[TBL] [Abstract][Full Text] [Related]
109. DNA-ploidy, G2M-fractions and prognosis of stages B and C prostate carcinoma.
Müller JG; Demel S; Wirth MP; Manseck A; Frohmüller HG; Müller HA
Virchows Arch; 1994; 424(6):647-51. PubMed ID: 8055159
[TBL] [Abstract][Full Text] [Related]
110. Cervical carcinoma DNA content, S-fraction, and malignancy grading. II. Comparison with clinical staging.
Adelson MD; Johnson TS; Sneige N; Williamson KD; Freedman RS; Peters LJ
Gynecol Oncol; 1987 Jan; 26(1):57-70. PubMed ID: 3792936
[TBL] [Abstract][Full Text] [Related]
111. Adenocarcinoma and mixed carcinoma of the uterine cervix. II. Prognostic value of nuclear DNA analysis.
Fu YS; Reagan JW; Fu AS; Janiga KE
Cancer; 1982 Jun; 49(12):2571-7. PubMed ID: 7074574
[TBL] [Abstract][Full Text] [Related]
112. Uterine stromal neoplasms: a clinicopathologic and DNA flow cytometric correlation.
el-Naggar AK; Abdul-Karim FW; Silva EG; McLemore D; Garnsey L
Hum Pathol; 1991 Sep; 22(9):897-903. PubMed ID: 1916750
[TBL] [Abstract][Full Text] [Related]
113. Prognostic factors in carcinoma of the vulva: a clinicopathologic and DNA flow cytometric study.
Drew PA; al-Abbadi MA; Orlando CA; Hendricks JB; Kubilis PS; Wilkinson EJ
Int J Gynecol Pathol; 1996 Jul; 15(3):235-41. PubMed ID: 8811385
[TBL] [Abstract][Full Text] [Related]
114. [Flow cytometric analysis of DNA content in testicular seminomas--correlation to mitotic count].
Kashiwagi A; Nagamori S; Nonomura K; Toyota K; Koyanagi T; Nojima T; Inoue K
Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):239-45. PubMed ID: 2041270
[TBL] [Abstract][Full Text] [Related]
115. DNA ploidy and S-phase fraction as prognostic factors in cervical cancer.
Rothenberg ML
Cancer Treat Res; 1994; 70():53-62. PubMed ID: 8060751
[No Abstract] [Full Text] [Related]
116. DNA patterns and aggressive histopathologic features in 159 patients with cervical carcinoma.
Strang P; Lindgren A; Frankendal B; Stendahl U
Int J Gynecol Pathol; 1988; 7(1):56-63. PubMed ID: 3350617
[TBL] [Abstract][Full Text] [Related]
117. Small cell carcinoma of the cervix: a clinical and flow-cytometric study.
Miller B; Dockter M; el Torky M; Photopulos G
Gynecol Oncol; 1991 Jul; 42(1):27-33. PubMed ID: 1655594
[TBL] [Abstract][Full Text] [Related]
118. New prognostic factors in squamous cell carcinoma of cervix uteri.
Jakobsen A; Bichel P; Vaeth M
Am J Clin Oncol; 1985 Feb; 8(1):39-43. PubMed ID: 3993624
[TBL] [Abstract][Full Text] [Related]
119. Cancer of the cervix, FIGO stages IB and IIA: patterns of local growth and paracervical extension.
Landoni F; Bocciolone L; Perego P; Maneo A; Bratina G; Mangioni C
Int J Gynecol Cancer; 1995 Sep; 5(5):329-334. PubMed ID: 11578499
[TBL] [Abstract][Full Text] [Related]
120. Changes in S-phase fraction and micronucleus frequency as prognostic factors in radiotherapy of cervical carcinoma.
Zölzer F; Alberti W; Pelzer T; Lamberti G; Hülskamp FH; Streffer C
Radiother Oncol; 1995 Aug; 36(2):128-32. PubMed ID: 7501810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
